Phenotype measures set:   Graham1   WNV_IgM

ID, description, units MPD:63361   WNV_IgM   virus-specific IgM in serum, post infection   [ng/mL]
West Nile virus study
Measures • day 7    • day 12    • day 21    • day 28
Data set, strains Graham1   CC RIX   5 strains     sex: m     age: 8-10wks
Procedure immunoglobulin quantification
Comparisontimecourse but different cohorts
Ontology mappings

  SIDE-BY-SIDE STRAIN CURVES
Values
Graph Type
Dimensions Width:  ×  Height: px
Plot Options


  OVERLAPPING STRAIN CURVES
Data
Dimensions px
Toggle Series   
Plot Options

Graham1 - virus-specific IgM in serum, post infection





  ANOVA, Q-Q NORMALITY ASSESSMENT

ANOVA Summary     

Factor DF Sum of squares Mean sum of squares F value p-value (Pr>F)
group 3 4867.0332 1622.3444 20.0737 < 0.0001
strain 2 754.1641 377.0821 4.6657 0.0199
group:strain 6 667.9718 111.3286 1.3775 0.2654
Residuals 23 1858.8458 80.8194

Q-Q normality assessment based on residuals

  


  INDIVIDUAL MEASURES
ProjectIDDrug or
challenge
Description and varname PanelStrains
tested
SexAge
Graham1 63361 immunoglobulin quantification West Nile virus virus-specific IgM in serum, post infection   [ng/mL]   day 7   WNV_IgM_d7 CC RIX 5 m 8-10wks
Graham1 63362 immunoglobulin quantification West Nile virus virus-specific IgM in serum, post infection   [ng/mL]   day 12   WNV_IgM_d12 CC RIX 5 m 8-10wks
Graham1 63363 immunoglobulin quantification West Nile virus virus-specific IgM in serum, post infection   [ng/mL]   day 21   WNV_IgM_d21 CC RIX 4 m 8-10wks
Graham1 63364 immunoglobulin quantification West Nile virus virus-specific IgM in serum, post infection   [ng/mL]   day 28   WNV_IgM_d28 CC RIX 5 m 8-10wks